Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Guardant Health Inc (NASDAQ: GH) closed the day trading at $95.05 down -3.15% from the previous closing price of $98.14. In other words, the price has decreased by -$3.15 from its previous closing price. On the day, 9.8 million shares were traded. GH stock price reached its highest trading level at $95.24 during the session, while it also had its lowest trading level at $88.88.
On April 10, 2025, Mizuho started tracking the stock assigning a Outperform rating and target price of $55.Mizuho initiated its Outperform rating on April 10, 2025, with a $55 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 17 ’25 when Tariq Musa sold 116 shares for $66.95 per share. The transaction valued at 7,766 led to the insider holds 7,725 shares of the business.
POTTER MYRTLE S sold 26 shares of GH for $1,741 on Oct 17 ’25. The Director now owns 18,324 shares after completing the transaction at $66.95 per share. On Oct 17 ’25, another insider, Tariq Musa, who serves as the Director of the company, bought 116 shares for $66.95 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 11980206080 and an Enterprise Value of 12836070400. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.27. Its current Enterprise Value per Revenue stands at 14.222 whereas that against EBITDA is -31.915.
Stock Price History:
The Beta on a monthly basis for GH is 1.59, which has changed by 2.4326687 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, GH has reached a high of $100.22, while it has fallen to a 52-week low of $23.27. The 50-Day Moving Average of the stock is 43.54%, while the 200-Day Moving Average is calculated to be 85.22%.
Shares Statistics:
Over the past 3-months, GH traded about 2.68M shares per day on average, while over the past 10 days, GH traded about 3602540 shares per day. A total of 125.01M shares are outstanding, with a floating share count of 120.39M. Insiders hold about 4.49% of the company’s shares, while institutions hold 99.54% stake in the company. Shares short for GH as of 1760486400 were 8273789 with a Short Ratio of 3.09, compared to 1757894400 on 8744644. Therefore, it implies a Short% of Shares Outstanding of 8273789 and a Short% of Float of 6.950000000000001.
Earnings Estimates
A detailed examination of Guardant Health Inc (GH) is currently in progress, with 14.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.29 and low estimates of -$0.6.
Analysts are recommending an EPS of between -$0.64 and -$1.91 for the fiscal current year, implying an average EPS of -$1.71. EPS for the following year is -$1.4, with 16.0 analysts recommending between -$0.89 and -$2.31.
Revenue Estimates
18 analysts predict $267.76M in revenue for. The current quarter. It ranges from a high estimate of $270M to a low estimate of $264.82M. As of. The current estimate, Guardant Health Inc’s year-ago sales were $201.81MFor the next quarter, 18 analysts are estimating revenue of $269.72M. There is a high estimate of $284.1M for the next quarter, whereas the lowest estimate is $247.8M.
A total of 21 analysts have provided revenue estimates for GH’s current fiscal year. The highest revenue estimate was $970.1M, while the lowest revenue estimate was $965.57M, resulting in an average revenue estimate of $968.57M. In the same quarter a year ago, actual revenue was $739.02MBased on 22 analysts’ estimates, the company’s revenue will be $1.22B in the next fiscal year. The high estimate is $1.32B and the low estimate is $1.09B.
